BioPharma Dive - Latest News

SynWeave™: Revolutionizing biopharma manufacturing by improving titer, timelines and manufacturability

Enhancing manufacturability is crucial for reducing the risks associated with scaling production.

Mar 10, 2025 - 10:06
 0
SynWeave™: Revolutionizing biopharma manufacturing by improving titer, timelines and manufacturability

Enhancing manufacturability is crucial for reducing the risks associated with scaling production.

Read More

Tags:

Previous Article

3 ways to accelerate development and de-risk cell and gene therapy manufacturing

Next Article

UK Food & Drink Shows - presentations that manufacturers won’t want to miss!

Related Posts

Axsome secures top drug’s future with Teva patent settlement

Axsome secures top drug’s future with Teva patent settl...

Feb 10, 2025  0

AbbVie gets into obesity with $350M deal for once-weekly shot

AbbVie gets into obesity with $350M deal for once-weekl...

Mar 3, 2025  0

Bristol Myers gives first peek at closely watched launch of schizophrenia drug

Bristol Myers gives first peek at closely watched launc...

Feb 9, 2025  0